Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Prenuvo, a company specializing in preventative MRI scans, has successfully raised $120 million in its Series B funding round. The funding will be used to enhance access to proactive healthcare solutions, which include FDA-cleared AI body composition analysis, advanced brain health assessments, and comprehensive blood panels. With over 100,000 scans conducted, Prenuvo boasts the world's largest whole body imaging dataset, utilizing artificial intelligence to identify health patterns that traditional healthcare may overlook. The company aims to integrate multimodal diagnostics, potentially combining imaging and blood tests to detect conditions like cancer at earlier stages.
“Perhaps in the future, we get diagnosed with a multimodal scan that detects cancer before it shows up, with a blood draw and a scan. We can use the LLMs and [alternative] models, transformers and beyond––AlphaFold and things like AI-based companies for drug discovery… finding… https://t.co/krGIJxaL0l
Why I got a full-body MRI, & how Prenuvo uses AI: With over 100,000 scans, @Prenuvo has the world’s largest whole body imaging dataset, and their AI can uncover patterns across organs that traditional siloed healthcare might miss; for example, the relationship between visceral https://t.co/pDxnzQ2J0L
Prenuvo reveals $120m raise and adds new ‘enhanced’ health assessments Full body MRI company lands FDA clearance for body composition report and adds brain health and blood-based biomarker assessments. #longevity #investment #MRI #screening #prevention https://t.co/c0od2vX8RJ https://t.co/mIW4eycCNM
